Cargando…
Thioredoxin Glutathione Reductase as a Novel Drug Target: Evidence from Schistosoma japonicum
BACKGROUND: Schistosomiasis remains a major public health concern affecting billions of people around the world. Currently, praziquantel is the only drug of choice for treatment of human schistosomiasis. The emergence of drug resistance to praziquantel in schistosomes makes the development of novel...
Autores principales: | Song, LiJun, Li, JiaHuang, Xie, ShuYing, Qian, ChunYan, Wang, Jie, Zhang, Wei, Yin, XuRen, Hua, ZiChun, Yu, ChuanXin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3285170/ https://www.ncbi.nlm.nih.gov/pubmed/22384025 http://dx.doi.org/10.1371/journal.pone.0031456 |
Ejemplares similares
-
Identification of Peptide Antagonists to Thioredoxin Glutathione Reductase of Schistosoma japonicum
por: Song, Li-Jun, et al.
Publicado: (2018) -
Molecular docking to explore the possible binding mode of potential inhibitors of thioredoxin glutathione reductase
por: HUANG, JINGWEI, et al.
Publicado: (2015) -
Cheminformatics Models for Inhibitors of Schistosoma mansoni Thioredoxin Glutathione Reductase
por: Gaba, Sonam, et al.
Publicado: (2014) -
Gene Gun Bombardment with DNA-Coated Golden Particles Enhanced the Protective Effect of a DNA Vaccine Based on Thioredoxin Glutathione Reductase of Schistosoma japonicum
por: Cao, Yan, et al.
Publicado: (2013) -
Thioredoxin Glutathione Reductase from Schistosoma mansoni: An Essential Parasite Enzyme and a Key Drug Target
por: Kuntz, Angela N, et al.
Publicado: (2007)